Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia

  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Minguillón Pedreño, Jordi|||0000-0003-2124-8294
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Persico, Ilaria
  • Cavero, Debora|||0000-0002-8912-1890
  • de la Cal, Aurora
  • Río, Paula
  • Navarro Ordóñez, Susana|||0000-0002-0764-5384
  • Casado, José A.|||0000-0003-2479-1508
  • Bailador, Almudena
  • Sanchez de la Fuente, Antonio
  • López de Heredia, Miguel|||0000-0003-2826-9565
  • Almazán Castro, Francisco|||0000-0001-6894-9376
  • Antelo, Maria Luisa|||0000-0002-4280-4432
  • Argilés, Bienvenida
  • Badell Serra, Isabel|||0000-0001-6546-2175
  • Baragaño, Marta|||0000-0002-4041-2021
  • Beléndez, Cristina|||0000-0002-6019-6557
  • Bermúdez, Mar
  • Bernués, Marta
  • Buedo Rubio, María Isabel|||0000-0002-2967-1647
  • Carrasco, Estela|||0000-0003-1964-7675
  • Català, Albert|||0000-0003-0133-1752
  • Costa, Dolors|||0000-0002-8276-3292
  • Cuesta, Isabel
  • Fernandez-Delgado, Rafael
  • Fernandez-Teijeiro, Ana|||0000-0002-2359-9330
  • Figuera, Ángela
  • García, Marta|||0000-0001-5155-4730
  • Gondra, Ainhoa
  • González Cruz, Macarena
  • González Muñiz, Soledad
  • Hernandez-Rodriguez, Inés|||0000-0003-2550-9041
  • Ibañez, Fátima
  • Kelleher, Nicholas John
  • Lendínez, Francisco
  • Lopez Rodriguez, Monica|||0000-0001-8134-9682
  • López-Almaraz, Ricardo
  • Marchante, Inmaculada
  • Mendoza, Carmen
  • Nieto, José
  • Ojeda, Emilio
  • Payán-Pernía, Salvador|||0000-0002-4288-7362
  • Peláez, Irene
  • Pérez de Soto, Inmaculada
  • Portugal, Raquel|||0000-0002-7144-9409
  • Ramos-Arroyo, María A.|||0000-0002-7171-9202
  • Regueiro, Alexandra
  • Rodríguez, Ana
  • Rosell, Jordi
  • Saez, Raquel
  • Sánchez, José
  • Sánchez, Martha
  • Senent, Maria Leonor
  • Tapia, María
  • Trujillo-Quintero, Juan Pablo|||0000-0001-5901-9388
  • Vagace Valero, José Manuel|||0000-0001-8751-4319
  • Verdú-Amorós, Jaime|||0000-0002-0900-0889
  • Verdugo, Victória
  • Vidales, Isabel
  • Villarreal, Jasson
  • Díaz de Heredia, Cristina|||0000-0001-8086-296X
  • Sevilla, Julián|||0000-0002-6852-1860
  • Bueren, Juan|||0000-0002-3228-7013
  • Surralles, Jordi|||0000-0002-4041-7519
Fanconi anemia (FA) is a rare genetic disease characterized by high phenotypic and genotypic heterogeneity, and extreme chromosome fragility. To better understand the natural history of FA, identify genetic risk and prognostic factors, and develop novel therapeutic strategies, the Spanish Registry of Patients with FA collects data on clinical features, chromosome fragility, genetic subtypes, and DNA sequencing with informed consent of participating individuals. In this article, we describe the clinical evolution of 227 patients followed up for up to 30 years, for whom our data indicate a cumulative cancer incidence of 86% by age 50. We found that patients with lower chromosome fragility had a milder malformation spectrum and better outcomes in terms of later-onset hematologic impairment, less severe bone marrow failure, and lower cancer risk. We also found that outcomes were better for patients with mutations leading to mutant FANCA protein expression (genetic hypomorphism) than for patients lacking this protein. Likewise, prognosis was consistently better for patients with biallelic mutations in FANCD2 (mainly hypomorphic mutations) than for patients with biallelic mutations in FANCA and FANCG, with the lack of the mutant protein in patients with biallelic mutations in FANCG contributing to their poorer outcomes. Our results regarding the clinical impact of chromosome fragility and genetic hypomorphism suggest that mutant FA proteins retain residual activity. This finding should encourage the development of novel therapeutic strategies aimed at partially or fully enhancing mutant FA function, thereby preventing or delaying bone marrow failure and cancer in patients with FA. Clinical Trial Registration number: NCT06490510.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting protein-protein interactions in drug discovery, Modulators approved or in clinical trials for cancer treatment

  • Camps-Fajol, Cristina
  • Cavero, Debora|||0000-0002-8912-1890
  • Minguillón Pedreño, Jordi|||0000-0003-2124-8294
  • Surralles, Jordi|||0000-0002-4041-7519
Protein-protein interactions (PPIs) form complex cellular networks fundamental to many key biological processes, including signal transduction, cell proliferation and DNA repair. In consequence, their perturbation is often associated with many human diseases. Targeting PPIs offers a promising approach in drug discovery and ongoing advancements in this field hold the potential to provide highly specific therapies for a wide range of complex diseases. Despite the development of PPI modulators is challenging, advances in the genetic, proteomic and computational level have facilitated their discovery and optimization. Focusing on anticancer drugs, in the last years several PPI modulators have entered clinical trials and venetoclax, which targets Bcl-2 family proteins, has been approved for treating different types of leukemia. This review discusses the clinical development status of drugs modulating several PPIs, such as MDM2-4/p53, Hsp90/Hsp90, Hsp90/CDC37, c-Myc/Max, KRAS/SOS1, CCR5/CCL5, CCR2/CCL2 or Smac/XIAP, in cancer drug discovery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases

  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Natera-de Benito, Daniel|||0000-0001-7764-2085
  • Kapetanovic, Solange
  • Hernández-Laín, Aurelio
  • Estévez-Arias, Berta|||0000-0002-1711-7489
  • Llansó, Laura|||0000-0003-4950-7657
  • Ortez, Carlos
  • Jou, Cristina|||0000-0002-2223-7880
  • Martí-Carrera, Itxaso
  • López-Márquez, Arístides
  • Rodríguez, Maria José
  • González Mera, Laura
  • Nedkova, Velina
  • Fernández-Torrón, Roberto
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
  • Juntas Morales, Raúl|||0000-0003-2205-1741
  • López-de Munain, Adolfo
  • Surralles, Jordi|||0000-0002-4041-7519
  • Nascimento, Andrés
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
  • Gallano, Pia|||0000-0001-8104-2197
  • González Quereda, Lidia|||0000-0003-0715-6414
Objective: Approximately half of patients with hereditary myopathies remain without a definitive genetic diagnosis after DNA next-generation sequencing (NGS). Here, we implemented transcriptome analysis of muscle biopsies as a complementary diagnostic tool for patients with muscle disease but no definitive genetic diagnosis after exome sequencing. Methods: In total, 70 undiagnosed cases with suspected genetic muscular dystrophies or congenital myopathies were included in the study. Muscle RNAseq comprised the analysis of aberrant splicing, aberrant expression, and monoallelic expression. In addition, existing NGS data or variant calling from RNAseq were reanalyzed, and genome sequencing was performed in selected cases. Four aberrant splicing open-source tools were compared and assessed. Results: RNAseq established a diagnosis in 10/70 patients (14.3%) by identifying aberrant transcripts produced by single nucleotide variants (7/10) or copy number variants (3/10). Reanalysis of NGS data allowed the diagnosis in 9/70 individuals (12.9%). Based on this cohort, FRASER was the tool that reported more splicing outlier events per sample while showing the highest accuracy (81.26%). Conclusions: We demonstrate the utility of RNAseq in identifying causative variants in muscle diseases. Evaluation of four aberrant splicing tools allowed efficient identification of most pathogenic splicing events, obtaining a manageable number of candidate events for manual inspection, demonstrating feasibility for translation into a clinical setting. We also show how the integration of omic technologies reduces the turnaround time to identify causative variants.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features

  • Llansó, Laura|||0000-0003-4950-7657
  • Stevanovski, Igor
  • Morís, Germán|||0000-0001-7608-2194
  • Collet Vidiella, Roger|||0000-0003-1668-1018
  • Segarra Casas, Alba|||0000-0001-5185-5031
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Gallano, Pia|||0000-0001-8104-2197
  • Alvarez, Rodrigo
  • Vesperinas-Castro, Ana|||0000-0003-1919-9382
  • Blanco, Rosa
  • San-Millán, Beatriz
  • Navarro, Carmen|||0000-0003-4445-8585
  • Illa, Isabel|||0000-0002-2186-2684
  • Ravenscroft, Gianina|||0000-0003-3634-211X
  • W. Deveson, Ira
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
Objective: We aim to describe and characterize two unrelated Spanish families suffering from an autosomal dominant autophagic vacuolar myopathy caused by repeat expansions in PLIN4. Methods: We evaluated the clinical phenotype and muscle imaging, and performed a genetic workup that included exome sequencing, muscle RNAseq, and long-read genome sequencing. Muscle pathology was assessed by means of histochemistry, electron microscopy, PLIN4, p62, LC3, and NBR1 immunofluorescence and/or western blotting. Detailed characterization of autophagic vacuoles was performed. Results: Patients presented around the age of 30 with mild proximal weakness followed by prominent distal weakness in lower legs, eventually spreading to other muscle groups. Muscle biopsies showed unique pathological features characterized by numerous rimmed vacuoles that displayed sarcolemmal features and were located beneath the sarcolemma and within the cytoplasm. Ultrastructural studies showed autophagic vacuoles, replications, and loops of the basal lamina and tubulofilamentous sarcoplasmic inclusions. p62 and NBR1 co-localized with PLIN4 at the sarcolemma and vacuoles. LC3 immunoreactivity and other lysosomal markers were increased at the vacuoles. Targeted long-read sequencing of PLIN4 in affected individuals revealed a single expanded allele of 39 × 99 bp repeats in family 1 and of 37 × 99 bp repeats in family 2. Interpretation: We characterize two new families suffering from an autosomal dominant myopathy carrying repeat expansions in PLIN4. Subsarcolemmal p62 expression is a powerful although nonspecific marker of this disease. No correlation between the size of the expansion and clinical severity can be clearly established. PLIN4 expansions should be considered in the diagnosis of autosomal dominant vacuolar myopathies, especially when sarcolemmal features are present.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ending diagnostic odyssey by reanalysis of whole exome sequencing data, reclassification of suspected Fanconi anemia cases to dyskeratosis congenita and Diamond-Blackfan anemia

  • Tejero Laguna, Eudald|||0000-0002-7536-4322
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Surralles, Jordi|||0000-0002-4041-7519
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
Initial Whole Exome Sequencing frequently fails to resolve rare disease cases. Bioinformatic reanalysis of existing genomic data utilizes advancing knowledge to enhance diagnosis without additional testing. This study investigated six patients with clinical features consistent with Fanconi Anemia but negative chromosomal breakage tests, whose initial genetic analyses were inconclusive. Whole Exome Sequencing data from these patients (collected 2005-2009) underwent comprehensive reanalysis, including single nucleotide variants, insertions/deletions, and copy number variants across genes beyond those typically associated with Fanconi Anemia. Telomere length was assessed via monochrome multiplex quantitative PCR. Reanalysis identified clinically significant variants in two patients (33.3% yield): one harboured a heterozygous pathogenic loss-of-function variant in the Diamond-Blackfan anemia gene RPL5, while the second exhibited compound heterozygous variants in the TERT gene, indicative of dyskeratosis congenita. This study underscores the clinical value of reanalyzing existing genomic data in unresolved suspected genetic disorders, even when phenotype-specific assays are negative. The 33.3% diagnostic yield aligns with gains from larger reanalysis studies (10-25%). Systematic reassessment after sufficient time (24 + months) for genomic advancements offers a cost-effective diagnostic approach for long-undiagnosed cases, highlighting the dynamic nature of genomic interpretation as gene-disease understanding evolves. The online version contains supplementary material available at 10.1186/s13023-025-03928-5.